Castellum, Inc. (CTM) - 10-K Summary for Fiscal Year Ended December 31, 2024
Business Context and Reporting Period
Company: Castellum, Inc.
Filing Type: Form 10-K (Annual Report)
Period: Fiscal year ended December 31, 2024
Business Overview: Castellum is a technology company focused on cybersecurity, IT, electronic warfare, and information operations, primarily serving U.S. federal, state, and local government agencies. The company operates through a single segment and relies heavily on government contracts, including Time and Materials (T&M), Cost Plus Fixed Fee (CPFF), and Firm Fixed Price (FFP) arrangements.
Recent Activity: The company sold a subsidiary (MFSI) in September 2024 and executed multiple equity offerings in late 2024 to raise capital.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Revenue | $44,764,852 | $45,243,812 | (1.1)% |
| Gross Profit | $18,266,415 | $18,675,327 | (2.2)% |
| Gross Margin | 40.8% | 41.3% | -0.5 pts |
| Net Loss | $(9,980,307) | $(17,800,178) | 43.9% improvement |
| Net Loss to Common Shareholders | $(10,099,584) | $(17,918,330) | 43.6% improvement |
| Operating Cash Flow | $1,120,105 | $(2,264,447) | Positive vs. Negative |
| Cash & Equivalents (End of Period) | $12,005,048 | $1,830,841 | Significant Increase |
| Total Debt (Notes Payable) | $8,000,000 | $8,221,764 | Reduced |
| Accumulated Deficit | $(54,082,484) | $(43,982,900) | Increased |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased by 1.1% primarily due to the divestiture of Mainnerve Federal Services, Inc. (MFSI) in September 2024.
- Operating Expense Reduction: Total operating expenses dropped 27.8% to $25.5 million. This was driven by a $6.9 million non-cash goodwill impairment charge in 2023 that did not recur in 2024, and a $3.4 million reduction in General and Administrative (G&A) expenses due to cost-saving initiatives and lower stock-based compensation.
- Profitability Improvement: Net loss narrowed significantly by 43.9% year-over-year, aided by the absence of the prior year's goodwill impairment and improved operating efficiency.
- Liquidity Surge: Cash on hand increased from $1.8 million to $12.0 million, fueled by three equity offerings in 2024 (raising approx. $10 million gross) and warrant exercises.
- Debt Restructuring: The company extinguished several notes and restructured others, extending maturities to 2026. A $2.0 million revolving credit facility with Live Oak Bank was active but fully repaid in February 2025 (subsequent event).
Guidance, Outlook, Risks, and Unusual Items
- Backlog: Total backlog as of December 31, 2024, was $100.5 million (excluding unscheduled options). Funded backlog was $12.7 million, while unfunded backlog was $15.4 million. The company expects to recognize ~28% of remaining performance obligations in the next 12 months.
- Outlook: Management expects to continue generating a net loss in 2025. The company relies on government appropriations and is subject to budgetary uncertainties, including potential Continuing Resolutions (CR) or government shutdowns.
- Key Risks:
- Government Dependency: Substantially all revenue comes from U.S. government contracts, which are subject to termination for convenience and funding delays.
- Capital Needs: The company has a history of net losses and an accumulated deficit of $54 million. Continued profitability is not guaranteed, and additional capital raises may be necessary, potentially causing dilution.
- Debt Service: Significant debt obligations mature in 2025 and 2026. Failure to generate sufficient cash flow could force asset sales or dilutive financing.
- Goodwill: Goodwill of $10.7 million is subject to impairment testing; a $6.9 million charge was recorded in 2023.
- Unusual Items:
- Derivative Liabilities: A loss of $725,600 was recorded in 2024 due to changes in the fair value of derivative liabilities associated with convertible notes and warrants.
- Self-Insurance: The company began self-insuring healthcare risks in June 2024, creating a reserve of $79,217.
Investor Verification Checklist
- Debt Maturities: Verify the ability to service $1.2 million in principal payments due in 2025 and $6.8 million in 2026 without further dilutive equity raises.
- Backlog Conversion: Assess the risk that the $15.4 million unfunded backlog may not be appropriated by Congress in the upcoming fiscal year.
- Revenue Concentration: Confirm the status of the top three contracts, which accounted for 49% of 2024 revenue, and their renewal prospects.
- Equity Dilution: Review the impact of outstanding options (9.5 million shares) and warrants (8.7 million shares) on future earnings per share.
- Government Funding: Monitor U.S. federal budget negotiations and the potential impact of Continuing Resolutions on contract start dates and payments.